Dr. Jennifer Primeggia, MD

Dr. Primeggia practices at VHC Health in Arlington, Virginia, part of VHC Health.

Dr. Primeggia's NPI, 1174782056, was assigned on June 5, 2008. Dr. Primeggia graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2006. Dr. Primeggia holds Virginia license 0101244429.

Dr. Primeggia's primary practice is VHC Health, at 1701 North George Mason Drive, Arlington, VA 22205 in Arlington County. The practice phone is (703) 558-5000.

Dr. Primeggia's primary practice is VHC Health in Arlington, Virginia, part of VHC Health. The medical group on file is Inova Urgent Care Center. Dmand AI also links Dr. Primeggia to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Primeggia practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Primeggia's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Primeggia is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Primeggia's licenses on file in 2 states: Virginia and District of Columbia.

Dmand AI lists hiv/aids, joint or bone infection, pneumonia, UTI and yeast infection among the conditions Dr. Primeggia treats.

CMS data shows 1,389 Medicare services from Dr. Primeggia across 9 procedure codes in 2024, for 277 Medicare patients. Medicare paid $161,511 for them.

CMS counts 277 Medicare patients who saw Dr. Primeggia in 2024. The largest group is 75 to 84, with 105 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.93, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Primeggia's median patient age at 71, with 48% women.

In 2024, Dr. Primeggia wrote 663 Medicare Part D claims for 105 patients. 88% of them were for generic drugs. CMS names the drug for 517 of them, across 20 drugs with 11 or more claims each, at $151,776 in total drug cost. In 2023, CMS named 232 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Primeggia for performance year 2024, reported as part of a group. Dr. Primeggia accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Primeggia as offering telehealth.

Dmand AI links 3 papers to Dr. Primeggia in 2013. 2013 was the busiest year, with 2. The most frequent topics are Organ Transplantation. Dr. Primeggia's most frequent co-authors are Joseph G. Timpone, Thomas Fishbein, MD and Cal Matsumoto, MD.

Dmand AI links Dr. Primeggia to 1 clinical trial. Conditions studied include HIV Infections and Lentivirus Infections.

CMS Open Payments shows 76 general payments to Dr. Primeggia from 5 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $1,023.

Dr. Primeggia graduated from Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School in 2006. Dr. Primeggia is a member of Infectious Disease Society of America.

Dr. Primeggia is in network with 18 carriers, including Aetna, United Healthcare and CareFirst BlueCross BlueShield. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.